AMYLASE MONOREAGENT

Back

CLINICAL SIGNIFICANCE
The concentration of a-Amylase in infants is low and rises to adult levels at the end of the first year of life.

Serum amylase is increased in parotitis, pancreatitis, intestinal obstruction, strangulated bowel, ectopic pregnancy, diabetic ketoacidosis, peritonitis, pancreatic cyst or pseudocyst, macroamylasemia, renal failure, head injury, viral infections, biliary tract diseases, post-operational patients, some lung and ovarian tumors, intestinal trauma. a-Amylase levels are decreased in cases of pancreatic insufficiency, advanced cystic fibrosis, and in severe liver diseases.

Amylase in urine is increased in all the cases mentioned for serum, except in renal failure and macroamylasemia. In these last cases, urine amylase levels are normal or decreased. Amylase levels may remain increased in urine up to 2 weeks after an acute pancreatitis episode and may be related to the formation of pseudocyst.

The determination of is done with the use of GalG2CNP as substrate.
CHARACTERISTICS

Form: Liquid ready-to-use
Shelf life: 18 months @ 2-8 C
On-Board Stability: 30 days
Sample: Serum, or heparinised-plasma, urine
Detection limit: 0.0 U/L
Linearity: 1800 U/L (urine 4500 U/L)


Packaging
For Use On
MEDILYZER
EX-OLYMPUS
GENERAL PURPOSE
SIEMENS ADVIA
Packaging
8x90 Tests
4x200 Tests & 4x500 Tests
R1 4x100 mL
Please Request Info